Neurocrine Biosciences, Inc.
Ticker
NBIX
ISIN
US64125C109
Price
USD 140.55
Change Today
-1.10 / -0.777 %
Price 1 year ago
95.27 / 47.528 %
Market Capitalization
9,948,672,000.00
52 Week Low
89.53
52 Week High
143.74
200 Day Moving Average
124.66
50-day Moving Average
138.67
Price evolution
Yearly Returns
Peers
Peers
Company information
Summary
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, a VMAT2 inhibitor for the treatment of tardive dyskinesia. The company's commercial products include ONGENTYS, a catechol-O-methyltransferase inhibitor used as an adjunct therapy to levodopa/DOPA decarboxylase inhibitors for patients with Parkinson's disease; ORILISSA for the management of moderate to severe endometriosis pain in women; and ORIAHNN, a non-surgical oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. Its product candidates in clinical development include NBI-921352 for treating pediatric patients, as well as adult focal epilepsy indications; and NBI-827104 to treat rare pediatric epilepsy and essential tremor. The company's products in clinical development also comprise NBI-1065845 for the treatment of major depressive disorder; NBI-1065846 for treating anhedonia in major depressive disorder; and NBI-118568 for the treatment of schizophrenia. It has license and collaboration agreements with Heptares Therapeutics Limited; Takeda Pharmaceutical Company Limited; Idorsia Pharmaceuticals Ltd; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; BIAL Portela & Ca, S.A.; Mitsubishi Tanabe Pharma Corporation; and AbbVie Inc. Neurocrine Biosciences, Inc. was incorporated in 1992 and is headquartered in San Diego, California.
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Country
United States
Exchange
NMS
Earnings Per Share
4.16
P/E Ratio
25.209137
Debt/Equity Ratio
35.734
Beta
0.638143
Ebitda
191,100,000.00
Ebitda Margins
0.16
Enterprise to Ebitda
46.20
Enterprise Value
8,828,830,720.00
Target Price
111.95
Estimated Price
-
Book Value
12.04
Expected Growth
-
Balance sheet
Income statement
Sustainability
Correlation
| Company | Name | Correlation |
|---|---|---|
| SIDO.JK | Industri Jamu dan Farmasi Sido | -0.18 |
| MCOA | MARIJUANA COMPANY OF AMERICA IN | -0.17 |
| 600781.SS | FUREN GROUP PHARMACEUTICAL CO L | -0.15 |
| 600518.SS | KANGMEI PHARMACEUTICAL CO LTD | -0.13 |
| 300142.SZ | WALVAX BIOTECHNOLO | -0.10 |
| 300110.SZ | HUAREN PHARMACEUTI | -0.08 |
| 600196.SS | SHANGHAI FOSUN PHARMACEUTICAL G | -0.08 |
| SFLM | SFLMAVEN CORP | -0.06 |
| TLRY | Tilray Brands, Inc. - Class 2 | -0.05 |
| 300239.SZ | BAOTOU DONGBAO BIO | 0.00 |
| 002001.SZ | ZHEJIANG NHU CO | 0.04 |
| 600216.SS | ZHEJIANG MEDICINE | 0.05 |
| 600252.SS | GUANGXI WUZHOU ZHONGHENG GROUP | 0.08 |
| 300194.SZ | FUAN PHARMACEUTICA | 0.11 |
| 300026.SZ | TIANJIN CHASE SUN | 0.15 |
| HLN.L | HALEON PLC | 0.20 |
| 0570.HK | TRAD CHI MED | 0.20 |
| 600062.SS | CHINA RESOURCES DOUBLE-CRANE PH | 0.20 |
| 300534.SZ | GANSU LONGSHENRONG | 0.20 |
| 300158.SZ | SHANXI ZHENDONG PH | 0.21 |
| 300199.SZ | HYBIO PHARMACEUTIC | 0.21 |
| 600079.SS | HUMANWELL HEALTHCARE (GROUP) CO | 0.23 |
| 600277.SS | ELION CLEAN ENERGY CO LTD | 0.25 |
| TEVA | Teva Pharmaceutical Industries | 0.26 |
| 600750.SS | JIANGXI JIANGZHONG PHARMACEUTIC | 0.27 |
| 600380.SS | JOINCARE PHARMACEUTICAL GROUP I | 0.27 |
| 0460.HK | SIHUAN PHARM | 0.30 |
| 300039.SZ | SHANGHAI KAIBAO PH | 0.31 |
Similar companies
| Ticker | Name | City | Country | Currency | Exchange | Beta | EV/EBITDA | Employees | Site |
|---|---|---|---|---|---|---|---|---|---|
| MCOA | MARIJUANA COMPANY OF AMERICA IN | Los Angeles | United States | USD | PNK | 1.15 | -1.91 | 7 | https://www.marijuanacompanyofamerica.com |
| 600277.SS | ELION CLEAN ENERGY CO LTD | Beijing | China | CNY | SHH | 0.81 | 14.08 | 3926 | https://www.elion.cn |
| 300026.SZ | TIANJIN CHASE SUN | Tianjin | China | CNY | SHZ | -0.10 | 16.16 | https://www.chasesun.cn | |
| ENDP | Endo International plc | Dublin | Ireland | USD | NMS | 1.12 | 9.59 | 3103 | https://www.endo.com |
| 300110.SZ | HUAREN PHARMACEUTI | Qingdao | China | CNY | SHZ | 0.86 | 22.14 | 2242 | https://www.qdhuaren.com |
| 600518.SS | KANGMEI PHARMACEUTICAL CO LTD | Puning | China | CNY | SHH | 0.26 | -11.18 | 6410 | https://www.kangmei.com.cn |
| 600062.SS | CHINA RESOURCES DOUBLE-CRANE PH | Beijing | China | CNY | SHH | -0.16 | 12.21 | 11029 | https://www.dcpc.com |
| 600079.SS | HUMANWELL HEALTHCARE (GROUP) CO | Wuhan | China | CNY | SHH | 0.87 | 13.32 | 15746 | https://www.humanwell.com.cn |
| SIDO.JK | Industri Jamu dan Farmasi Sido | Semarang | Indonesia | IDR | JKT | 0.14 | 15.04 | 3081 | https://www.sidomuncul.co.id |
| 600196.SS | SHANGHAI FOSUN PHARMACEUTICAL G | Shanghai | China | CNY | SHH | 0.65 | 30.59 | 36279 | https://www.fosunpharma.com |
| HLN.L | HALEON PLC | Weybridge | United Kingdom | GBp | LSE | 16.31 | 22000 | https://www.haleon.com | |
| 002001.SZ | ZHEJIANG NHU CO | Xinchang | China | CNY | SHZ | 0.31 | 10.45 | 10805 | https://www.cnhu.com |
| 0460.HK | SIHUAN PHARM | Wan Chai | Hong Kong | HKD | HKG | 0.61 | 7.15 | 4282 | https://www.sihuanpharm.com |
| TLRY | Tilray Brands, Inc. - Class 2 | Leamington | Canada | USD | NMS | -28.58 | https://www.tilray.com | ||
| 300199.SZ | HYBIO PHARMACEUTIC | Shenzhen | China | CNY | SHZ | 0.02 | -117.98 | 885 | https://www.hybio.com.cn |
| 0570.HK | TRAD CHI MED | Wan Chai | Hong Kong | HKD | HKG | 0.51 | 5.97 | 17098 | https://www.china-tcm.com.cn |
| 600216.SS | ZHEJIANG MEDICINE | Shaoxing | China | CNY | SHH | -0.16 | 7.75 | 5901 | https://www.zmc.top |
| 300194.SZ | FUAN PHARMACEUTICA | Chongqing | China | CNY | SHZ | 0.41 | 15.82 | 3004 | https://www.fapharm.com |
| 300039.SZ | SHANGHAI KAIBAO PH | Shanghai | China | CNY | SHZ | 0.31 | 32.28 | 1432 | https://www.xykb.com |
| 300142.SZ | WALVAX BIOTECHNOLO | Kunming | China | CNY | SHZ | 0.62 | 56.64 | https://www.walvax.com | |
| 300239.SZ | BAOTOU DONGBAO BIO | Baotou | China | CNY | SHZ | 0.26 | 43.88 | 1354 | https://www.dongbaoshengwu.com |
| 600252.SS | GUANGXI WUZHOU ZHONGHENG GROUP | Wuzhou | China | CNY | SHH | 0.39 | 56.88 | 3453 | https://www.wz-zhongheng.com |
| 300158.SZ | SHANXI ZHENDONG PH | Changzhi | China | CNY | SHZ | 0.32 | 5.06 | 4123 | https://www.zdjt.com |
| 600781.SS | FUREN GROUP PHARMACEUTICAL CO L | Shanghai | China | CNY | SHH | 0.27 | -5.14 | 2916 | https://www.shfuren.cn |
| ZOM | Zomedica Corp. | Ann Arbor | United States | USD | ASE | 0.59 | -3.10 | 47 | https://www.zomedica.com |
| 300534.SZ | GANSU LONGSHENRONG | Lanzhou | China | CNY | SHZ | 0.38 | 195.38 | 302 | https://www.lsrfzy.com |
| SFLM | SFLMAVEN CORP | Leamington Spa | United Kingdom | USD | PNK | 3.15 | -1.48 | 1 | https://www.dnadynamicsinc.com |
| 600750.SS | JIANGXI JIANGZHONG PHARMACEUTIC | Nanchang | China | CNY | SHH | 0.40 | 9.25 | 4153 | https://www.jzjt.com |
| 600380.SS | JOINCARE PHARMACEUTICAL GROUP I | Shenzhen | China | CNY | SHH | 0.66 | 6.07 | 13234 | https://www.joincare.com |
| TEVA | Teva Pharmaceutical Industries | Tel Aviv | Israel | USD | NYQ | 1.22 | 7.45 | 34713 | https://www.tevapharm.com |
| 600521.SS | ZHEJIANG HUAHAI PHARMACEUTICAL | Linhai | China | CNY | SHH | 0.22 | 30.80 | 7019 | https://www.huahaipharm.com |
| 600664.SS | HARBIN PHARMACEUTICAL GROUP CO | Harbin | China | CNY | SHH | 9.55 | https://www.hayao.com | ||
| 300401.SZ | ZHEJIANG GARDEN BI | Dongyang | China | CNY | SHZ | -0.24 | 14.95 | 742 | https://www.hybiotech.com |
| 600568.SS | ZHONG ZHU HEALTHCARE HOLDING CO | Zhuhai | China | CNY | SHH | 0.45 | -231.66 | 1286 | https://www.zz600568.com |
| CGC | Canopy Growth Corporation | Smiths Falls | Canada | USD | NMS | 2.23 | -2.61 | 3151 | https://www.canopygrowth.com |
| DVLP | GOLDEN DEVELOPING SOLUTIONS INC | Fort Lauderdale | United States | USD | PNK | 1.60 | https://goldendeveloping.com | ||
| SIGA | SIGA Technologies Inc. | New York | United States | USD | NGM | 0.40 | 12.13 | 39 | https://www.siga.com |
| 3320.HK | CHINARES PHARMA | Wan Chai | Hong Kong | HKD | HKG | 0.42 | 9.52 | 65000 | https://www.crpharm.com |
| 300601.SZ | SHENZHEN KANGTAI B | Shenzhen | China | CNY | SHZ | 0.31 | 17.71 | 2445 | https://www.biokangtai.com |
| 600267.SS | ZHEJIANG HISUN PHARMACEUTICAL C | Taizhou | China | CNY | SHH | 0.53 | 11.17 | 8280 | https://www.hisunpharm.com |
Funds
Mutual Fund Holders
Social
Dividends
Ratings
News
Earnings
SEC Filings
Options
Indicators
Glossary
- Momentum
- A technical indicator that measures the rate of change in price movements over a specific period. It indicates the strength or weakness of a price trend.
Assessment: A positive momentum value generally indicates a good trend, while a negative value suggests a weak or downward trend.
- Inertia
- In trading, inertia refers to the tendency of prices to continue moving in their current direction. It suggests that an asset's price will likely maintain its current trend.
Assessment: A higher inertia value is generally considered good, as it indicates a strong and sustained price trend.
- Relative Strength Index (RSI)
- A momentum oscillator that measures the speed and change of price movements. It helps identify overbought or oversold conditions in an asset.
Assessment: An RSI value above 70 is typically considered overbought and may suggest a potential reversal or correction. Conversely, an RSI value below 30 is often considered oversold, indicating a possible upward price correction.
- Fibonacci's Weighted Moving Average
- A technical indicator that assigns different weights to recent data points, giving more significance to recent prices. It helps smooth out price fluctuations and identify trend reversals.
Assessment: The interpretation of the Fibonacci's Weighted Moving Average value depends on its comparison to other moving averages or trendlines. A value above 50 may indicate an uptrend, while a value below 50 may suggest a downtrend.
- Williams %R
- A momentum indicator that measures overbought or oversold conditions in an asset. It shows the relationship of the current closing price to the high-low range over a specified period.
Assessment: Williams %R values above -20 are typically considered overbought and may indicate a potential price reversal. Values below -80 are often viewed as oversold, suggesting a potential price bounce.
- Relative Volatility Index (RVI)
- A technical indicator that measures the volatility of a security by comparing the magnitude of recent price movements to the magnitude of average price changes. It helps identify periods of high or low volatility.
Assessment: A higher RVI value suggests higher volatility, which can provide trading opportunities but also carries increased risk.
- Commodity Channel Index (CCI)
- A versatile indicator that measures the current price level relative to an average price level over a given period. It helps identify overbought or oversold conditions and potential trend reversals.
Assessment: CCI values above 100 are often considered overbought, indicating a potential price correction or reversal. Values below -100 are typically viewed as oversold, suggesting a potential price rebound.